What’s Going On With Chemical Giant Dow Shares Today?
DOW's Q1 FY24 results beat expectations with sales up 1% and EPS at $0.56. Company remains confident in long-term potential and shareholder value.
Magnificent 7 Tumble, Wipe Out $300 Billion On Meta’s Weak Guidance, Q1 Stagflation Woes
Tech stocks plummet as Magnificent 7 giants lose $303B in market value. Meta Platforms issues weak guidance, GDP growth slows and inflation rises.
US Growth Slows In Q1, Yet Inflation Acceleration Signals Stagflation: ‘The Worst Possible Outcome For The Fed’
US economy disappointed in growth, but inflation exceeded predictions, causing stagflation. Experts warn of negative impact on economy & markets.
Drugmaker Sanofi’s Strong Dupixent And Beyfortus Vaccine Sales Propel Q1 Earnings
Sanofi reports Q1 operating income at 2.8 billion euros, down 14.7%. Beat consensus EPS at $0.97. Sales reach $11.36 billion, led by Dupixent's 24.9% surge. Vaccine sales up 5.6%. Expecting Dupixent to hit €13 billion in 2024 sales. Blockbuster ambitions for Beyfortus.
Why Is American Airlines Stock Seeking Blue Skies Today?
American Airlines reported Q1 financial results with a midpoint above estimates. Revenue increased but adjusted EPS missed consensus. Company reduced debt and expects 2024 adjusted EPS of $1.15-$1.45 and reiterated FY24 outlook of $2.25-$3.25.
AstraZeneca Posts Bumper Earnings On Strong Sales From Cancer Drugs, Sticks To Annual Guidance
AstraZeneca reports Q1 sales of $12.68 billion, up 17% Y/Y. Despite missing adjusted EPADS, oncology sees a 26% surge, driven by Tagrisso and Imfinzi. Cardiovascular sales up 20%. R&D up 18%. Fiscal 2024 outlook: low double-digit revenue and EPS growth.
Why Oil & Gas Major Equinor Shares Are Higher Premarket Thursday
Equinor ASA reported $24.79B in revenue, up 2% Y/Y, and $0.96 in adjusted EPS, beating consensus of $0.80. Share buyback and dividend announced.
World’s Largest Miner BHP Bids To Takeover Anglo American As Hunt For Resources Intensify
BHP makes a bold move, initiating a bid for Anglo American. Anglo disclosed receiving an unsolicited merger proposal. This deal could redefine the mining landscape, establishing the world's top copper producer and attracting industry competitors.
Tesla Posts Strongest Session Since January 2022: Is A Trend Reversal Underway?
Tesla stock surges 12% despite falling short on Q1 earnings. Investors optimistic about future revenue, backed by upgraded rating and positive catalysts.
Biogen/Eisai’s Popular Alzheimer’s Drug Leqembi Is Seeing Slow Adoption – Here’s Why
Discover the challenges facing Leqembi, the first Alzheimer's drug shown to slow progression. Skepticism among doctors and concerns about efficacy and costs hinder widespread adoption despite FDA approval.